Not Signed In - Lawsuit Might Reduce FDA Authority In Allowing Terminally Ill Patients To Use Experimental Medications
Fri, 16 Feb 2007 01:00 AM EST
... The U.S. Court of Appeals for the District of Columbia on March 1 will reconsider a case that "threatens to shake the foundations of the FDA's regulatory authority covering pharmaceuticals and lead to greatly expanded use" of experimental medications, the Newark Star-Ledger reports (Cohen, Newark Star-Ledger, 2/12). [click link for full article] ...
Related Topics
- Celecoxib
- Rofecoxib
- Asbestos
- Food Safety
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Tacrolimus ointment
- Electrical Safety
- Smoking Cessation and Continued Risk in Cancer Patients
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Mammography
- Emergency Medical Services
- Carcinogens
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Rosuvastatin
- Immunosuppressive Medications
email this page
print this page
bookmark this page
feedback on this page
